FDA Warns CBD Sellers Over Opioid Addiction Relief Claims
The U.S. Food and Drug Administration on Thursday told a pair of CBD companies to stop marketing products as treatments for opioid addiction, part of the agency's ongoing efforts to stamp...To view the full article, register now.
Already a subscriber? Click here to view full article